Press release
Influenza Pipeline Drugs 2024 | Moderna, SAB Biotherapeutics, ENA Respiratory Pty Ltd, Codagenix, AlloVir, Osivax, CureVac AG
DelveInsight's, "Influenza Pipeline Insight 2024" report provides comprehensive insights about 120+ companies and 120+ pipeline drugs in Influenza pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.Discover the latest drugs and treatment options in the Influenza Pipeline. Dive into DelveInsight's comprehensive report today! @ Influenza Pipeline Outlook [https://www.delveinsight.com/sample-request/influenza-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Influenza Pipeline Report
* August 2024:- Hoffmann-La Roche- A Phase IIIb Multicenter, Single-Arm, Open-Label Surveillance Study of Susceptibility to Baloxavir Marboxil in Patients With Influenza. The purpose of this study is to evaluate the pre-treatment and single-dose post treatment susceptibility of baloxavir marboxil in participants aged 1 to
* August 2024:- Janssen Vaccines & Prevention B.V.- A Randomized, Double-blind, Placebo-controlled, First-in-human Phase 1/2a Study to Evaluate Safety, Reactogenicity and Immunogenicity of a Universal Influenza (Uniflu) Vaccine With INFLUENZA G1 mHA in Healthy Adults. The primary purpose of this study is to evaluate safety/ reactogenicity of INFLUENZA G1 mini-hemagglutinin stem-derived protein vaccine antigen (mHA), with or without Al(OH)3 adjuvant, in healthy adults greater than or equal to (>=) 18 to less than or equal to (
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Influenza Pipeline Drugs 2024 | Moderna, SAB Biotherapeutics, ENA Respiratory Pty Ltd, Codagenix, AlloVir, Osivax, CureVac AG here
News-ID: 3635365 • Views: …
More Releases from ABNewswire
Vinchy Art Review: DEESPAEK Evaluates the Leading Wellness-Oriented Abstract Pai …
In 2026, the art world is experiencing a notable shift toward wellness-focused creations, and Vinchy Art has emerged as a prominent player in this sector. Founded in 2019 and launching its online store in August 2023, Vinchy Art has gained recognition for its high-quality, handcrafted abstract oil paintings that blend visual aesthetics with mental well-being. According to DEESPAEK [https://www.deespaek.com/vinchy-art-review-elevating-spaces-with-abstract-wellness-art-in-2026/], an independent review platform dedicated to objective product analysis, Vinchy Art…
Robert Michael Diamonds Makes Premium Quality Accessible with IGI-Certified Lab- …
Robert Michael Diamonds, LLC. transforms the diamond buying experience by offering IGI-certified F/VS lab-grown diamonds that combine exceptional beauty with outstanding value. The company leverages over 50 years of fine jewelry experience and 55 years in manufacturing to curate diamonds that meet exacting standards while remaining beautifully within reach. This approach makes luxury accessible to consumers who value both quality and affordability.
Robert Michael Diamonds, LLC. is reshaping expectations in the…
Vinchy Art Review: Independent Assessment Highlights Mindful and Contemporary Ho …
In an era where home environments play a critical role in emotional well-being, Vinchy Art [https://www.deespaek.com/vinchy-art-review-elevating-home-spaces-with-mindful-art-and-tranquility/], a Singapore-based contemporary art brand, is drawing attention for its ability to harmonize interior spaces while promoting a sense of calm. DEESPAEK, an independent review platform known for expert, unbiased evaluations, recently conducted a comprehensive assessment of Vinchy Art's offerings, analyzing design quality, emotional impact, and overall usability in modern living spaces.
Abstract and Textured…
Dimmer Switch Two-Way Setup: Repenic Launches New Zigbee Dimmer to Revolutionize …
Repenic [https://www.repenic.com/], the fast-growing smart home brand known for combining premium design with affordable pricing, today announced the launch of its latest Zigbee-enabled dimmer switch designed specifically for two-way lighting circuits. The new product is engineered to simplify installation in older UK homes-especially those lacking neutral wires-while enabling modern smart control and elegant aesthetics across the home.
The new Repenic Zigbee dimmer expands the company's growing portfolio of smart home devices,…
More Releases for Influenza
Multivalent Influenza Vaccines Market Advancing Influenza Prevention Strategies …
The "Multivalent Influenza Vaccines Market" research report represents major insights on the current growth dynamics as well as the primary revenue generation elements that are available in the Multivalent Influenza Vaccines industry along with various other factors over the predicted period 2024-2030. The report on the Multivalent Influenza Vaccines market is focusing on a series of parameters including top manufacturing strategies, industry share, prime opportunities, industrial channels, profit margin, etc.…
Influenza Diagnostics Market - Rapid Detection, Effective Protection: Influenza …
Newark, New Castle, USA: The "Influenza Diagnostics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Influenza Diagnostics Market: https://www.growthplusreports.com/report/influenza-diagnostics-market/8780
This latest report researches the industry structure, sales, revenue,…
Influenza Medication Market - Fight off the influenza virus with effective and r …
Newark, New Castle, USA: The "Influenza Medication Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Influenza Medication Market: https://www.growthplusreports.com/report/influenza-medication-market/7859
This latest report researches the industry structure, sales, revenue,…
Influenza Medication Market - Revolutionizing Flu Treatment: Innovating Advanced …
Newark, New Castle, USA - new report, titled Influenza Medication Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Influenza Medication market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Influenza Medication market. The report offers an overview of the market, which…
Influenza Vaccines Market - Empowering Strength, Nurturing Immunity: Innovating …
Newark, New Castle, USA - new report, titled Influenza Vaccines Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Influenza Vaccines market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Influenza Vaccines market. The report offers an overview of the market, which…
H1N1 Influenza (Swine Influenza) Market to Witness Growth by 2032, Estimates Del …
DelveInsight's "H1N1 Influenza (Swine Influenza) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of H1N1 Influenza (Swine Influenza), historical and forecasted epidemiology as well as the H1N1 Influenza (Swine Influenza) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The H1N1 Influenza (Swine Influenza) market report provides current treatment practices, emerging drugs, the market share of the individual therapies,…
